Mindfulness Texting for Medication Adherence and Chronic Pain Management
RecruitingNot applicableNCT07711795
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The goal of this clinical trial is to examine the effects of reminder and mindfulness text messages based on integrated Acceptance and Commitment Therapy and Mindfulness Based Relapse Prevention (ACT+MBRP) on medication adherence and managing craving, pain, mindfulness, and withdrawal symptoms in people taking medications for opioid use disorder and with chronic pain through assessment questions collected six times daily during the course of treatment. The main questions it aims to answer are: 1. Do daily medication reminder text messages increase medication adherence for people taking medications for opioid use disorder? 2. To what extent do people engage with the daily mindfulness messages? 3. Do participants receiving a structured curriculum of mindfulness messages delivered twice daily differ from those receiving randomly selected mindfulness messages delivered four times daily in engagement with the intervention? 4. How do the two mindfulness text messaging interventions differ in their effects on intervention engagement, craving, pain, mindfulness, and withdrawal symptoms? Participants will: 1. Receive daily medication reminder text messages for 12 weeks (i.e., 3 months) 2. Receive either 2 or 4 mindfulness messages per day for 6 weeks 3. Answer brief assessment questions six times per day during the 6-week mindfulness text messaging period 4. Complete questionnaires at enrollment (baseline), once each week during the 6-week mindfulness text messaging period (6 total), immediately after the 6-week mindfulness text messaging period (post-treatment), and 6 weeks after the mindfulness text messaging period ends (follow-up)
Study details
- Official title
- Integrating Mindfulness and mHealth Approaches for Treating Opioid Use Disorder and Chronic Pain
- Conditions
- Opioid Use Disorder (OUD)
- Chronic Pain
- Interventions
- Behavioral: Mindfulness text messages
- Sponsor
- University of New Mexico
- Collaborators
- National Institute on Drug Abuse (NIDA)
- Start date
- 2025-04-23
- Primary completion
- 2027-07
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age 18 years or older * Reside in the United States * Own or have access to a mobile phone capable of sending and receiving text messages * Have reliable internet access to complete study surveys * Be willing and able to comply with all study procedures and remain available for the duration of the study * Be interested in receiving medication reminders and mindfulness text messages * Be within 2 months of initiating or restarting methadone or buprenorphine treatment for opioid use * Report chronic pain (pain lasting at least 3 months) * Live in the United States Exclusion Criteria: * None
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07711795